Exhibiting at FOOD INGREDIENTS CHINA 2025

Tianjin Tianyao Pharmaceuticals Co., Ltd. (津药药业股份有限公司), headquartered in Tianjin, China, is a leading manufacturer in the Chinese pharmaceutical sector, with a strong international footprint. The company specializes in the production of corticosteroid active pharmaceutical ingredients (APIs), amino acids, and a full range of finished dosage forms, serving the needs of both domestic and global healthcare markets.

Core Business and Offerings

Tianyao Pharmaceuticals is known for its vertically integrated production model that includes research, API synthesis, formulation manufacturing, and global distribution. The company’s portfolio spans prescription medications, hospital injectables, and essential APIs used in a variety of therapeutic classes.

Product Categories:

• Corticosteroid APIs:

  • Dexamethasone Series
  • Prednisone & Prednisolone
  • Hydrocortisone Acetate
  • Methylprednisolone
  • Triamcinolone
  • Fluocinolone

  These APIs are used globally for their anti-inflammatory and immunosuppressive effects across a range of medical indications, including autoimmune disorders, dermatological diseases, and oncology.

• Amino Acids:

  • A variety of pharmaceutical-grade amino acids used in parenteral nutrition and other formulations.

• Finished Dosage Forms:

  • Tablets
  • Injections
  • Ointments and Creams
  • Hard Capsules
  • Pills
  • Freeze-Dried Powder Injections
  • Inhalation Preparations

  These formulations support therapeutic needs across multiple clinical areas, including respiratory, dermatology, gastroenterology, and emergency medicine.

Specialization and Unique Strengths

Tianyao Pharmaceuticals has developed a global reputation for its corticosteroid API production, ranking among the top suppliers in China and maintaining consistent demand from multinational pharmaceutical companies.

Key competitive strengths include:

• GMP-certified production lines
• Regulatory approvals in major markets, including US FDA, EU EMA, and PMDA Japan for selected APIs
• Strong R&D team focusing on process optimization and generic drug development

The company supports both branded and generic pharmaceutical manufacturers worldwide, offering reliable, large-scale API production with full documentation support.

Financial and Operational Data

Tianjin Tianyao Pharmaceuticals is part of Tianjin Pharmaceuticals Group, a state-owned enterprise, and is listed on the Shenzhen Stock Exchange (stock code: 600129). In recent fiscal years, the company has reported:

• Annual revenue exceeding RMB 2 billion
• Export revenue accounting for more than 30% of total sales
• Presence in over 60 countries and regions worldwide

The company operates several manufacturing and R&D sites, including GMP-certified API plants and formulation facilities within pharmaceutical industry zones in Tianjin.

Shipment Records

According to international trade and customs data, Tianyao Pharmaceuticals exports substantial quantities of:

• Dexamethasone and Hydrocortisone APIs to North America, Europe, and Southeast Asia
• Finished injectable steroids to Latin America and Middle East under local licensing and contract manufacturing agreements

Their API export volumes place them among China’s top corticosteroid exporters, supporting hundreds of formulation customers globally.

Target Market

Tianyao Pharmaceuticals serves:

• Generic drug manufacturers seeking reliable corticosteroid API supply
• International pharmaceutical companies requiring contract manufacturing of injectable and topical corticosteroids
• Government and hospital procurement programs in emerging markets
• Nutritional and clinical care companies using amino acid raw materials

The company also collaborates on co-development and out-licensing of formulations in regulated markets.

Capabilities and Facilities

The company operates:

• GMP-certified API production sites with fermentation and chemical synthesis capabilities
• Dedicated formulation plants for sterile and non-sterile production
• R&D center equipped with HPLC, GC-MS, dissolution testing, stability chambers, and pilot scale production labs
• International regulatory affairs team supporting DMF filings, CEP applications, and ANDAs

Certifications and Compliance

Tianjin Tianyao Pharmaceuticals is certified by and compliant with:

• China NMPA GMP standards
• US FDA inspection and API registration (for selected corticosteroids)
• EU EMA certifications (COS/CEP) for APIs
• ISO 14001 and OHSAS 18001 environmental and occupational safety systems

The company has filed DMFs in multiple ICH countries and supports eCTD submissions.

Customer Feedback

Long-term international clients praise Tianyao for:

• Consistent quality and batch-to-batch reproducibility
• On-time delivery and strong export logistics
• Regulatory documentation and audit readiness
• Responsive technical support and stability data provision

The company’s experience with stringent regulatory markets has positioned it as a preferred partner for contract manufacturing and API sourcing.

Major Achievements

• Recognized as National High-Tech Enterprise by Chinese authorities
• Holds over 50 patents in pharmaceutical process development
• Listed API supplier for global Top 50 pharmaceutical companies
• Supported over 30 ANDA/MA filings globally with its corticosteroid APIs
• Played a vital role in COVID-19 emergency supply chains, providing corticosteroids to international healthcare systems

Tianjin Tianyao Pharmaceuticals Co., Ltd. continues to drive pharmaceutical innovation and manufacturing excellence, supporting global healthcare systems with quality-assured APIs and therapeutic products.